Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities

S. E. McAnaw, A. C. Hesseling, J. A. Seddon, K. E. Dooley, A. J. Garcia-Prats, S. Kim, H. E. Jenkins, H. S. Schaaf, T. R. Sterling, C. R. Horsburgh

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


On June 17, 2016, RESIST-TB, IMPAACT, Vital Strategies, and New Ventures jointly hosted the Pediatric Multidrug Resistant Tuberculosis Clinical Trials Landscape Meeting in Arlington, Virginia, USA. The meeting provided updates on current multidrug-resistant tuberculosis (MDR-TB) trials targeting pediatric populations and adult trials that have included pediatric patients. A series of presentations were given that discussed site capacity needs, community engagement, and additional interventions necessary for clinical trials to improve the treatment of pediatric MDR-TB. This article presents a summary of topics discussed, including the following: current trials ongoing and planned; the global burden of MDR-TB in children; current regimens for MDR-TB treatment in children; pharmacokinetics of second-line anti-tuberculosis medications in children; design, sample size, and statistical considerations for MDR-TB trials in children; selection of study population, design, and treatment arms for a trial of novel pediatric MDR-TB regimens; practical aspects of pediatric MDR-TB treatment trials; and strategies for integrating children into adult tuberculosis trials. These discussions elucidated barriers to pediatric MDR-TB clinical trials and provided insight into necessary next steps for progress in this field. Investigators and funding agencies need to respond to these recommendations so that important studies can be implemented, leading to improved treatment for children with MDR-TB.

Original languageEnglish (US)
Pages (from-to)194-199
Number of pages6
JournalInternational Journal of Infectious Diseases
StatePublished - Mar 1 2017


  • MDR tuberculosis
  • MDR-TB Pediatric Clinical trials
  • Multidrug-resistant tuberculosis
  • Tuberculosis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities'. Together they form a unique fingerprint.

Cite this